Alvotech SA ALVO
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Alvotech S.A. is a global biopharmaceutical company specializing in the development, manufacturing, and delivery of high-quality biosimilar medicines. Biosimilars are biologic products highly similar to approved reference medicines, designed to expand patient access to affordable treatments for conditions in areas such…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryLuxembourg
Employees1,012
TickerALVO
Statistics
Market Cap$1.23B
Revenue (TTM)$534.2M
Net Income—
Net Margin—
EPS—
P/E42.40
P/S2.30
P/B-4.64
EV/EBITDA25.77
ROE-9.8%
Dividend Yield—
Price$3.94
Data: Twelve Data · Revenue = mcap / P/S